Genetic Testing Proposed for All Women ≤65 With Breast Cancer
Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes.
Genetic Testing
DTC Genetic Tests: High Rate of False-Negative Results May Hide a Clinical Pearl
Before you discount the results of a DTC genetic test, explore your patient’s reason for undergoing the testing and consider the appropriateness of a referral for medical-grade testing.
Multigene Testing for All Breast Cancer Patients Cost-Effective
Findings support expansion of genetic testing to all women with breast cancer.
How Culturally Competent Care Is Different for Jewish Women With Breast Cancer
A review of the cultural and religious beliefs of Ashkenazi Jewish women that may challenge adherence to breast cancer screening and genetic testing recommendations.
Molecular Features May Predict Response in Primary Pancreatic Cancer
The goal of this study was to determine how molecular features change when PDAC progresses from a primary tumor to metastatic disease.
Barriers to Prostate Cancer Research in Black Men Identified
Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation
Frequency of Reclassifications of Genetic Testing Results Is Low
A retrospective analysis of genetic testing results at one laboratory reports that reclassifications occurs in approximately one-quarter of tests, resulting in both downgrades and upgrades of variant classifications.
Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
In a randomization of women with early-stage breast cancer, researchers explored the potential benefits of chemotherapy for women whose Oncotype DX RS was midrange.
Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
Investigators conducted a case-control study of 3030 pancreatic cancer patients in an attempt to confirm which genes might render patients susceptible to pancreatic cancer.
Patient Interest in Melanoma Genetic Risk Testing is Fairly High
Researchers examined interest in MC1R testing in the general population and assessed patterns across demographic and skin cancer risk factors.
Next post in Melanoma
